This is a preview of subscription content, log in via an institution to check access.
References
Cotter PD, Rucknagel DL, Bishop DF (1994) X-linked sideroblastic anemia: identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley. Blood 84(11):3915–3924
Cotter PD, May A, Li L, Al-Sabah AI, Fitzsimons EJ, Cazzola M, Bishop DF (1999) Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis. Blood 93(5):1757–1769
Sussman NL, Lee PL, Dries AM, Schwartz MR, Barton JC (2008) Multi-organ iron overload in an African-American man with ALAS2 R452S and SLC40A1 R561G. Acta Haematol 120(3):168–173. https://doi.org/10.1159/000181183
Peto TE, Pippard MJ, Weatherall DJ (1983) Iron overload in mild sideroblastic anaemias. Lancet (London, England) 1(8321):375–378
Cox TC, Bottomley SS, Wiley JS, Bawden MJ, Matthews CS, May BK (1994) X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase. N Engl J Med 330(10):675–679. https://doi.org/10.1056/nejm199403103301004
Cotter PD, May A, Fitzsimons EJ, Houston T, Woodcock BE, al-Sabah AI, Wong L, Bishop DF (1995) Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts. J Clin Invest 96(4):2090–2096. https://doi.org/10.1172/jci118258
Sankaran VG, Ulirsch JC, Tchaikovskii V, Ludwig LS, Wakabayashi A, Kadirvel S, Lindsley RC, Bejar R, Shi J, Lovitch SB, Bishop DF, Steensma DP (2015) X-linked macrocytic dyserythropoietic anemia in females with an ALAS2 mutation. J Clin Invest 125(4):1665–1669. https://doi.org/10.1172/jci78619
Aivado M, Gattermann N, Rong A, Giagounidis AA, Prall WC, Czibere A, Hildebrandt B, Haas R, Bottomley SS (2006) X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patterns. Blood Cells Mol Dis 37(1):40–45. https://doi.org/10.1016/j.bcmd.2006.04.003
Funding
This study was supported by the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2019-RC-HL-001, for CXX), the CAMS Innovation Fund for Medical Sciences (Grant No. 2016-12 M-1-002, for LJ), the National Key Research and Development Program of China (Grant No. 2016YFC0901503, for LJ), and China Postdoctoral Science Foundation Grant (2018 M631396, for CL).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Informed consent was obtained before conducting the whole-exome and Sanger sequencing experiments. This study was performed in accordance with the ethical standards provided in the 1964 Declaration of Helsinki and its later amendments.
Conflict of interest
The authors declare that have no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Qiu, Y., Cai, H., Cui, L. et al. Identification of a novel heterozygous ALAS2 mutation in a young Chinese female with X-linked sideroblastic anemia. Ann Hematol 99, 371–373 (2020). https://doi.org/10.1007/s00277-019-03894-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-019-03894-6